Literature DB >> 10484693

Parallel short forms for the Boston Naming Test: psychometric properties and norms for older adults.

P S Fastenau1, N L Denburg, B A Mauer.   

Abstract

Four 15-item and two 30-item short forms for the Boston Naming Test were validated using 108 non-neurological community-dwelling adults, ages 57-85. All forms were administered to all participants (counterbalanced), with no effect of administration sequence on any score. An age effect emerged (Multiple R = .28, p< or =.01). No effects for education or gender were found, nor were there any interactions (p> or = .10). Descriptive data are stratified by age group. Reliability and validity for each form were demonstrated in several ways. These short forms should be very useful as screening instruments and/or as alternate forms for the BNT in test-retest clinical protocols, pre-post experimental designs, and longitudinal research.

Entities:  

Mesh:

Year:  1998        PMID: 10484693     DOI: 10.1076/jcen.20.6.828.1105

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  25 in total

Review 1.  Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure.

Authors:  Marc R Bothe; Ingo Uttner; Markus Otto
Journal:  J Neural Transm (Vienna)       Date:  2010-01-30       Impact factor: 3.575

2.  Auditory confrontation naming in Alzheimer's disease.

Authors:  Jason Brandt; Arnold Bakker; David Aaron Maroof
Journal:  Clin Neuropsychol       Date:  2010-10-27       Impact factor: 3.535

3.  A brief Spanish-English equivalent version of the Boston Naming Test: a Project FRONTIER study.

Authors:  Danielle R Jahn; Cortney B Mauer; Chloe V Menon; Melissa L Edwards; Jeffrey A Dressel; Sid E O'Bryant
Journal:  J Clin Exp Neuropsychol       Date:  2013-09-02       Impact factor: 2.475

4.  Effects of distinctive encoding on source-based false recognition: further examination of recall-to-reject processes in aging and Alzheimer disease.

Authors:  Benton H Pierce; Jill D Waring; Daniel L Schacter; Andrew E Budson
Journal:  Cogn Behav Neurol       Date:  2008-09       Impact factor: 1.600

5.  Regression-Based Norms for a Bi-factor Model for Scoring the Brief Test of Adult Cognition by Telephone (BTACT).

Authors:  Ashita S Gurnani; Samantha E John; Brandon E Gavett
Journal:  Arch Clin Neuropsychol       Date:  2015-02-27       Impact factor: 2.813

6.  Diagnosing mild cognitive impairment in Parkinson's disease: which tests perform best in the Italian population?

Authors:  Angela Federico; Michela Trentin; Giampietro Zanette; Daniela Mapelli; Alessandro Picelli; Nicola Smania; Michele Tinazzi; Stefano Tamburin
Journal:  Neurol Sci       Date:  2017-05-26       Impact factor: 3.307

7.  Neuropsychological Test Norms in Cognitively Intact Oldest-Old.

Authors:  Zarui A Melikyan; Maria M Corrada; Malcolm B Dick; Christina Whittle; Annlia Paganini-Hill; Claudia H Kawas
Journal:  J Int Neuropsychol Soc       Date:  2019-05       Impact factor: 2.892

8.  The association between systemic inflammation and cognitive performance in the elderly: the Sydney Memory and Ageing Study.

Authors:  Julian N Trollor; Evelyn Smith; Emmeline Agars; Stacey A Kuan; Bernhard T Baune; Lesley Campbell; Katherine Samaras; John Crawford; Ora Lux; Nicole A Kochan; Henry Brodaty; Perminder Sachdev
Journal:  Age (Dordr)       Date:  2011-08-19

9.  Neuropathologic Associations of Learning and Memory in Primary Progressive Aphasia.

Authors:  Stephanie Kielb; Amanda Cook; Christina Wieneke; Alfred Rademaker; Eileen H Bigio; Marek-Marsel Mesulam; Emily Rogalski; Sandra Weintraub
Journal:  JAMA Neurol       Date:  2016-07-01       Impact factor: 18.302

10.  Item analysis of three Spanish naming tests: a cross-cultural investigation.

Authors:  Carlos Marquez de la Plata; Juan Carlos Arango-Lasprilla; Montse Alegret; Alexander Moreno; Luis Tárraga; Mar Lara; Margaret Hewlitt; Linda Hynan; C Munro Cullum
Journal:  NeuroRehabilitation       Date:  2009       Impact factor: 2.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.